FTO rs17814482: What Your Genotype Means
The rs17814482 variant is an intronic single nucleotide polymorphism located within the fat mass and obesity-associated (FTO) gene on chromosome 16. Extensive genome-wide association studies have linked this variant and its surrounding linkage block to modest differences in body mass index, adiposity, and risk of obesity. However, this genetic marker represents statistical susceptibility across large cohorts rather than a direct personal diagnosis.
What each genotype means
Baseline Body Weight Risk Profile
Research indicates that individuals with two copies of the common T allele do not carry the obesity-predisposing intronic FTO risk variant at this site. In population studies, this genotype is statistically associated with a baseline body mass index (BMI) and lower average adiposity compared to G allele carriers. However, body weight and metabolic outcomes remain polygenic and are heavily shaped by diet, physical activity, and broader environmental factors.
Carried by approximately 30% to 36% of individuals of European ancestry and roughly 65% to 75% of individuals of East Asian and African ancestry.
Moderately Elevated Obesity Predisposition
Carrying one copy of the G allele is associated in genome-wide and candidate-gene studies with a modest increase in average body mass index (BMI) and fat mass relative to non-carriers. Evidence indicates that this genetic signal tags regulatory enhancers within the first intron of the FTO locus, but the overall per-allele effect on weight is small (typically equivalent to less than 1 kg/m² in BMI). Furthermore, observational and clinical trials show that physical exercise and dietary modifications can substantially attenuate or offset this associated predisposition.
Carried by approximately 45% to 50% of individuals of European ancestry and about 25% to 32% of individuals in East Asian and African populations.
Higher Adiposity and BMI Predisposition
Individuals homozygous for the minor G allele have two copies of the risk-associated variant, which studies link to higher average BMI, increased fat mass, and elevated statistical odds of developing overweight or obesity compared to the TT genotype. While the statistical association across large cohorts is reproducible, the variant is a low-penetrance susceptibility marker rather than a direct diagnostic cause of metabolic disease. Lifestyle factors such as regular physical activity and sustained nutritional habits remain the dominant determinants of individual weight management regardless of genotype status.
Carried by approximately 15% to 18% of individuals of European descent, but less than 4% of individuals in East Asian and African populations.
Genetic Location and Molecular Characteristics
The single nucleotide polymorphism rs17814482 is situated in the first intron of the FTO gene on chromosome 16q12.2. In human reference assemblies, the typical alleles identified at this specific position are guanine (G) and thymine (T), often also reported on complementary assay strands as cytosine (C). Because it resides in a non-coding intronic region, rs17814482 does not directly alter the amino acid sequence of any cellular protein. Instead, it forms part of a dense, highly conserved linkage disequilibrium block in intron 1 of the FTO locus that includes well-known metabolic markers such as rs9939609. Research indicates that non-coding variants in this genomic region can function as long-range regulatory elements. Rather than solely impacting the FTO transcript itself, these regulatory sequences have been shown to modulate the expression of neighboring homeobox genes, particularly IRX3 and IRX5, which influence adipocyte development, mitochondrial thermogenesis, and cellular lipid accumulation.
Biological Function of the FTO Gene
The FTO gene encodes a 2-oxoglutarate- and iron(II)-dependent nucleic acid demethylase. This nuclear enzyme is capable of removing methyl groups from RNA molecules, exhibiting a strong affinity for N6-methyladenosine modifications in single-stranded RNA. Through this epigenetic and post-transcriptional regulatory activity, FTO helps coordinate cellular energy balance, nutrient sensing, and metabolic pathways throughout the body. FTO is abundantly expressed in key metabolic tissues, particularly the hypothalamus, which acts as the brain's central processing hub for hunger, satiety, and energy expenditure. Functional and observational research indicates that variation across the FTO locus may alter neurological appetite regulation, satiety signaling after meals, and dietary preferences for energy-dense or high-fat foods. By shifting these subtle behavioral and physiological set points, genetic variability in FTO contributes to long-term differences in how individuals accumulate body fat over time.
Population Associations and Evidence Strength
Across large-scale genome-wide association studies (GWAS), common non-coding variation within FTO constitutes one of the most robustly replicated signals for elevated body mass index and predisposition to obesity. However, the overall evidence strength for rs17814482 specifically being the direct causal driver is classified as limited, because it is difficult to untangle its independent biological role from neighboring co-inherited variants in the same haplotype block. At the population level, each copy of the risk-associated allele typically correlates with an average body mass index increase of roughly 0.2 to 0.4 kg/m², corresponding to approximately 1 to 1.5 kilograms of body weight in an average-sized adult. While statistically significant across cohorts numbering in the hundreds of thousands, this effect size is small in absolute terms. In addition, linkage disequilibrium patterns differ significantly between ancestries, meaning that specific tagging markers do not confer identical risk signals across all ethnic backgrounds.
Actionability and Lifestyle Context
Carrying an obesity-associated genotype at rs17814482 is not a clinical diagnosis, nor is it a predetermined metabolic fate. A landmark systematic review and meta-analysis published in The BMJ analyzed data from randomized controlled trials and established that individuals carrying risk-associated FTO alleles respond just as effectively to diet, physical activity, and weight-loss interventions as non-carriers. Genetic variations in FTO account for only a minute fraction of overall body weight variance, which is primarily driven by polygenic networks interacting with nutritional patterns, physical activity, sleep, stress, and broader environmental exposures. Knowledge of an rs17814482 genotype cannot be used to select a customized diet or predict personal medical outcomes. Instead, it serves solely as an educational illustration of human polygenic variation. Standard evidence-based lifestyle choices remain the cornerstone of healthy weight management for all genotypes.
How common is this variant?
The minor allele frequency for rs17814482 is approximately 0.40 in populations of European ancestry, whereas it is lower in East Asian and African populations, typically ranging from 0.15 to 0.20.
Frequently asked questions
Does having a risk allele at rs17814482 mean I will become obese?
No. The variant is associated with only a tiny statistical difference in average body weight across entire populations. Obesity is a complex trait influenced by hundreds of genes alongside dietary habits, exercise, and environmental factors.
Will an FTO risk variant make it harder for me to lose weight?
Scientific evidence shows it will not. Large meta-analyses of clinical trials have demonstrated that people with risk-associated FTO genotypes lose weight just as successfully as non-carriers through standard diet and exercise programs.
Why do different genetic testing companies report different letters for this variant?
Genotyping assays can analyze either the forward or reverse DNA strand. Depending on the reporting platform, alleles for rs17814482 may be listed as G and T, or on the complementary strand as C and A.
Can my rs17814482 genotype tell me which diet to follow?
Current medical and scientific guidelines do not support using single FTO variants to recommend specific nutritional plans. Balanced, evidence-based dietary patterns improve metabolic health regardless of your genotype.
Sources & further reading
Educational information only, last refreshed 9/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17814482?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.